Duration of sweat cyclophosphamide excretion in patients undergoing a conditioning regimen of high-dose cyclophosphamide for hematopoietic stem-cell transplantation.

PURPOSE: To investigate the duration of cyclophosphamide (CPA) excretion in the sweat after administration when receiving high-dose CPA therapy as a conditioning regimen for hematopoietic stem-cell transplantation (HSCT). METHODS: Shirts and pillowcases samples (changed once a day) from 12 patients, categorized as groups 1 (n = 6), 2 (n = 4), and 3 (n = 2), receiving high-dose CPA therapy were collected, sealed, stored at 4°C, and mailed to an analytical facility for CPA estimation using LC-MS/MS. CPA was administered intravenously at a dose of 60 mg/kg on days 1, 2 (closed-system delivery for group 3), and samples were collected during days 1-4 (groups 1,3) or days 1-9 (group 2). RESULTS: CPA was detected in all 126 shirts and pillowcases. In 9 patients, excluding 1 patient who had fever during the study period and group 3 patients, the mean (range) rate of CPA excretion in sweat was 0.03% (0.01-0.12%). The mean CPA excretion in 9 patients adjusted for body weight was 19.9 µg/kg on day 1 and 0.3 µg/kg on day 4. CONCLUSIONS: This study showed that CPA was excreted for an extended duration in the patient's sweat, receiving a high-dose CPA therapy as a conditioning regimen against HSCT.

Atypical negative pressure pulmonary edema after extracorporeal membrane oxygenation therapy for COVID-19.

NPPE imaging findings were reported to show a preferential central and nondependent distribution. However, in our case, NPPE showed a peripheral accent pattern, resembling the ARDS pattern of COVID-19 pneumonia 4 months ago. Capillary damage from COVID-19 might still exist.

A preliminary study on the use of meconium for the assessment of prenatal exposure to heavy metals in Japan.

In recent years, there has been increasing interest in the relevance of environmental pollution to children's health. We investigated whether the concentrations of heavy metals in meconium can be used for the assessmet of prenatal exposure in Japan. Our study subjects were newborns whose mothers were hospitalized for childbirth at Tokai University Hospital between November 2010 and March 2011. The target compounds of this study were lead (Pb), cadmium (Cd) and arsenic (As). Meconium samples collected from 102 newborns were analyzed using ICPMS. The median concentrations of Pb and As in the meconium were 0.71 ppb and 0.03 ppb, respectively. The median concentration of Cd was below the limit of quantification. These concentration values are much lower than those used in previous studies. Further study is needed to compare the concentrations of heavy metals in biological samples and to investigate the availability of meconium for the assessment of exposure to heavy metals during pregnancy.